Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CHILDREN'S HOSPITAL

NPI: 1104819366 · NEW ORLEANS, LA 70118 · Children's Hospital · NPI assigned 08/23/2005

$150.93M
Total Medicaid Paid
1,583,325
Total Claims
1,381,104
Beneficiaries
336
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialFRAGOUSO, LUCIO (CFO)
NPI Enumeration Date08/23/2005

Related Entities

Other providers sharing the same authorized official: FRAGOUSO, LUCIO

ProviderCityStateTotal Paid
CHILDREN'S HOSPITAL NEW ORLEANS LA $24.37M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 159,451 $9.88M
2019 169,746 $12.49M
2020 135,639 $8.65M
2021 239,447 $19.38M
2022 304,058 $32.53M
2023 322,757 $35.48M
2024 252,227 $32.51M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 132,532 119,993 $51.32M
99284 Emergency department visit for the evaluation and management, high severity 57,367 51,992 $28.76M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 19,306 16,713 $11.28M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 281,939 255,601 $9.63M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 171,521 157,019 $8.58M
99282 Emergency department visit for the evaluation and management, low to moderate severity 15,463 14,517 $4.72M
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 47,518 42,448 $3.93M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 107,167 99,110 $3.17M
99215 Prolong outpt/office vis 53,771 49,353 $2.70M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 64,956 57,158 $2.33M
0202U Oncology (prostate), multianalyte, gene expression profiling 6,393 5,510 $1.65M
41899 Unlisted procedure, dentoalveolar structures 2,632 2,273 $1.57M
93325 6,068 5,244 $1.30M
72082 5,758 5,244 $1.19M
G0378 Hospital observation service, per hour 1,599 856 $1.16M
92551 25,257 22,412 $817K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 10,840 9,597 $788K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 27,488 25,724 $787K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 23,912 21,084 $735K
29705 4,281 3,623 $671K
71046 Radiologic examination, chest; 2 views 6,999 6,406 $633K
92587 5,210 4,702 $589K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1,861 1,548 $511K
54161 1,865 1,356 $452K
92567 5,338 4,657 $428K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 28,153 14,600 $379K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 406 343 $372K
80053 Comprehensive metabolic panel 35,398 27,177 $354K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 8,179 7,574 $349K
94010 1,684 1,531 $346K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 4,018 3,319 $334K
64642 1,273 1,069 $332K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4,502 3,578 $308K
94060 994 907 $299K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 35,978 26,894 $246K
76770 1,082 984 $246K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 2,151 1,964 $239K
95012 2,914 2,612 $238K
86003 2,893 2,086 $237K
42820 Tonsillectomy and adenoidectomy; younger than age 12 601 476 $230K
87634 3,361 3,018 $207K
36415 Collection of venous blood by venipuncture 71,761 59,724 $192K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,194 1,064 $186K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 1,647 1,476 $186K
90999 Unlisted dialysis procedure, inpatient or outpatient 717 38 $185K
94664 1,364 1,115 $182K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 19,213 17,841 $180K
54150 506 380 $176K
93321 652 579 $175K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 892 830 $173K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 6,330 1,899 $172K
72020 1,573 1,423 $171K
17110 1,004 879 $167K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 458 424 $146K
92060 1,515 1,339 $136K
90472 Immunization administration, each additional vaccine (list separately) 10,360 9,831 $117K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 298 272 $113K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4,868 1,526 $113K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4,784 4,172 $113K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 7,342 7,044 $108K
93320 481 436 $100K
90791 Psychiatric diagnostic evaluation 635 421 $92K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,082 792 $91K
70551 Magnetic resonance imaging, brain; without contrast material 102 92 $89K
83655 7,171 6,718 $86K
94760 3,441 3,023 $80K
74018 732 673 $79K
93304 266 242 $74K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 798 637 $68K
86756 4,761 4,339 $66K
97530 Therapeutic activities, direct patient contact, each 15 minutes 4,067 1,319 $65K
76825 324 274 $64K
95816 249 236 $62K
76827 336 274 $62K
99281 Emergency department visit for the evaluation and management, self-limited or minor 388 373 $61K
84443 Thyroid stimulating hormone (TSH) 4,019 3,664 $61K
73630 650 415 $59K
95951 58 41 $58K
83036 Hemoglobin; glycosylated (A1C) 5,985 5,468 $52K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,271 1,916 $52K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,151 1,085 $50K
84439 6,000 5,507 $50K
96138 723 417 $50K
96132 866 497 $50K
90834 Psychotherapy, 45 minutes with patient 574 322 $49K
86235 1,085 710 $48K
71045 Radiologic examination, chest; single view 516 461 $46K
92650 361 346 $46K
94726 148 130 $44K
J0561 Injection, penicillin g benzathine, 100,000 units 239 152 $43K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 749 616 $42K
82728 3,459 2,902 $41K
82784 2,200 2,006 $39K
87486 1,141 1,077 $39K
87581 1,137 1,075 $39K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 6,736 4,021 $39K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 1,470 1,400 $38K
85018 15,369 14,284 $37K
96127 3,808 2,700 $36K
86317 1,031 402 $35K
72170 240 232 $34K
87081 5,486 4,622 $31K
0071A 922 700 $31K
80050 General health panel 846 754 $30K
0072A 738 646 $28K
73610 381 279 $28K
73564 161 133 $27K
81003 12,834 11,325 $26K
76820 100 78 $26K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 787 697 $26K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 788 697 $25K
J1050 Injection, medroxyprogesterone acetate, 1 mg 144 129 $25K
92557 211 181 $24K
0002A 817 671 $24K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 727 641 $23K
73100 246 194 $22K
81025 3,443 2,977 $20K
76705 Ultrasound, abdominal, real time with image documentation; limited 72 64 $20K
80061 Lipid panel 1,802 1,585 $20K
42830 35 29 $20K
70486 45 37 $20K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 21 16 $19K
87086 Culture, bacterial; quantitative colony count, urine 2,939 2,536 $19K
70360 253 246 $19K
J0585 Injection, onabotulinumtoxina, 1 unit 890 593 $19K
74019 90 87 $18K
83735 3,685 2,615 $18K
94729 98 86 $18K
77072 167 159 $17K
83021 1,049 901 $17K
73140 185 157 $17K
82785 1,267 1,007 $16K
86140 3,295 2,965 $16K
0001A 752 638 $16K
95716 18 12 $15K
85045 4,005 3,413 $14K
86408 459 364 $14K
87807 1,035 976 $13K
86038 1,208 1,051 $13K
96361 Intravenous infusion, hydration; each additional hour 181 152 $13K
11900 39 29 $12K
96910 177 25 $12K
90378 41 15 $12K
92579 105 99 $11K
90474 1,632 1,572 $11K
83615 1,904 1,610 $11K
84100 2,761 2,000 $11K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 68 41 $11K
84146 733 598 $11K
92550 98 96 $10K
82248 2,339 1,727 $10K
92586 34 33 $10K
95819 36 34 $8K
93225 99 67 $8K
90686 3,175 2,823 $8K
83970 229 188 $8K
90832 Psychotherapy, 30 minutes with patient 87 81 $7K
73562 46 38 $7K
81001 2,690 2,334 $7K
87070 857 802 $7K
73110 59 53 $7K
69210 115 101 $7K
86039 623 591 $7K
95700 28 24 $6K
29075 116 95 $6K
31526 34 30 $6K
95714 13 12 $6K
85027 1,018 884 $6K
85652 2,317 2,114 $6K
00170 Anesthesia for intraoral procedures, including biopsy 86 78 $6K
82570 1,061 894 $5K
C1889 Implantable/insertable device, not otherwise classified 91 81 $5K
86812 538 380 $5K
80197 589 413 $5K
84403 219 180 $5K
85576 279 240 $4K
81229 44 35 $4K
83525 384 348 $4K
36591 79 49 $4K
90674 394 329 $4K
73130 56 38 $4K
84681 288 237 $3K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 10,703 8,566 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 167 151 $3K
82043 563 488 $3K
92582 30 29 $3K
86800 180 171 $3K
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 432 315 $3K
92285 26 24 $3K
77073 18 12 $3K
80076 218 185 $3K
86431 477 464 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 2,838 658 $2K
80048 Basic metabolic panel (calcium, ionized) 231 176 $2K
85730 507 410 $2K
83540 441 375 $2K
90670 3,164 2,922 $2K
73080 16 12 $2K
64643 659 423 $2K
86376 149 142 $2K
0296T 12 12 $2K
86160 138 101 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 39 39 $2K
81002 755 725 $2K
V5264 Ear mold/insert, not disposable, any type 27 27 $2K
92555 44 41 $2K
0082A 55 46 $2K
84466 137 125 $2K
92651 13 13 $2K
86592 541 461 $2K
92552 12 12 $2K
90651 496 466 $1K
86225 132 109 $1K
V5266 Battery for use in hearing device 151 129 $1K
85610 379 311 $1K
0081A 55 30 $1K
85046 174 153 $1K
84156 313 252 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,057 5,009 $1K
82977 185 139 $1K
83001 67 57 $1K
84305 59 52 $987.52
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 207 179 $958.79
00126 131 120 $856.93
83002 51 46 $851.92
93296 16 13 $755.40
87088 99 92 $737.97
G0475 Hiv antigen/antibody, combination assay, screening 90 69 $704.68
82670 28 25 $698.54
92201 22 12 $661.54
82962 190 176 $632.89
83690 144 109 $620.30
87799 23 12 $618.50
88738 148 143 $609.44
87077 55 51 $567.81
83520 13 13 $546.44
85651 163 153 $543.40
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 180 158 $521.97
76000 12 12 $512.50
82139 27 26 $468.50
G9035 Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) 12 12 $438.41
86256 35 34 $430.72
J3010 Injection, fentanyl citrate, 0.1 mg 5,764 4,904 $395.67
82310 75 72 $390.14
85007 155 111 $380.96
J2704 Injection, propofol, 10 mg 529 411 $360.98
87186 45 40 $346.96
90734 355 340 $303.17
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 69 62 $301.94
82390 28 26 $298.25
87205 76 69 $294.63
J7030 Infusion, normal saline solution , 1000 cc 33 25 $277.29
83789 13 13 $265.21
82373 27 26 $263.75
86430 52 48 $259.07
91307 2,147 1,635 $249.95
83918 13 13 $246.24
82261 14 14 $243.62
86364 52 40 $242.20
36416 130 122 $238.21
82017 13 13 $224.88
82379 13 13 $224.88
90715 110 105 $211.10
82947 59 49 $208.98
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 13 12 $203.25
90661 23 15 $201.40
J0131 Injection, acetaminophen, not otherwise specified,10 mg 387 342 $197.38
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 929 464 $185.47
J0690 Injection, cefazolin sodium, 500 mg 1,515 1,230 $174.29
87040 16 16 $165.12
83516 16 15 $161.42
87270 14 13 $155.74
82805 17 14 $143.39
97802 13 13 $140.10
83605 12 12 $130.57
99442 21 12 $129.48
90633 1,040 985 $127.51
J0696 Injection, ceftriaxone sodium, per 250 mg 13 12 $125.07
0358T 16 12 $117.36
87184 39 16 $82.28
99173 236 233 $79.50
J3490 Unclassified drugs 519 408 $66.00
Q0169 Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 26 24 $65.23
83550 13 12 $61.18
88720 12 12 $57.15
88342 262 241 $52.18
84035 13 13 $43.56
88304 362 295 $35.09
90685 676 620 $26.79
88305 Level IV - Surgical pathology, gross and microscopic examination 365 340 $23.73
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 231 121 $19.71
90744 225 215 $19.49
B4082 Nasogastric tubing without stylet 235 164 $17.28
J7120 Ringers lactate infusion, up to 1000 cc 214 177 $17.21
90656 109 108 $16.61
A6258 Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing 330 269 $14.64
99001 3,308 2,561 $14.25
J1885 Injection, ketorolac tromethamine, per 15 mg 205 177 $13.53
L3260 Surgical boot/shoe, each 21 18 $11.40
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 13 12 $9.51
91300 1,872 1,250 $5.44
96110 Developmental screening, with scoring and documentation, per standardized instrument 425 411 $5.30
95874 201 168 $4.90
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing 125 110 $4.88
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 248 226 $3.76
A6257 Transparent film, sterile, 16 sq. in. or less, each dressing 225 180 $3.20
91308 235 143 $0.36
90671 77 45 $0.01
90698 1,668 1,559 $0.00
90680 1,148 1,079 $0.00
90716 103 103 $0.00
81374 128 103 $0.00
88300 90 78 $0.00
90647 141 123 $0.00
90743 316 293 $0.00
90619 18 12 $0.00
C9290 Injection, bupivacaine liposome, 1 mg 358 295 $0.00
64430 24 13 $0.00
90723 129 122 $0.00
J0586 Injection, abobotulinumtoxina, 5 units 34 26 $0.00
91305 16 13 $0.00
99174 37 28 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 24 19 $0.00
99417 Prolong home eval add 15m 50 41 $0.00
90697 19 12 $0.00
90696 25 25 $0.00
L8613 Ossicula implant 44 39 $0.00
90681 57 51 $0.00
90707 92 92 $0.00
00920 32 28 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 72 59 $0.00
90700 12 12 $0.00
90648 12 12 $0.00
81243 14 13 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 16 13 $0.00
90710 13 13 $0.00